Searching for Silence: Corneal Sensitivity Testing in NK

Thanks for your interest in this podcast. Please read this important program information before listening.

Episode Description

In this podcast, experts Francis Mah, MD; and Amy Nau, OD, FAAO, Dipl, CCLRT; discuss how to identify neurotrophic keratitis in practice, highlighting indications for corneal sensitivity testing based on patient history and examination findings. Faculty will also examine how to stage and treat neurotrophic keratitis once diagnosed.

Learning Objectives

Upon successful completion of this activity, you should be better prepared to:

• Describe the signs and symptoms that contribute to a diagnosis of neurotrophic keratitis, including reduced or absent corneal sensitivity
• Integrate the Mackie classification system to stage neurotrophic keratitis as part of the comprehensive clinical evaluation
• Summarize recommendations for corneal sensitivity testing based on patient history and clinical findings

Acknowledgment of Educational Grant Support

This activity is supported by an educational grant from Dompé US.

Faculty:

Francis Mah, MD

Director, Cornea Service
Co-Director, Refractive Surgery Service
Scripps Clinic Torrey Pines
La Jolla, CA

Disclosures: Advisor, Consultant, Speaker, Honoraria Recipient: AbbVie, Alcon, Aperta, Azura, Bausch + Lomb, BioTissue, BVI, ClearSight, Evolve, Eyenovia, EyeYon, Glaukos, Invirsa, iView, Johnson & Johnson Vision, Kala Bio, Lenz Therapeutics, OcuTerra, OSRX, PMN, PolyActiva, Puget Sound Therapeutics, Signal12, Sophia Bio, STAAR, Sydnexis, Tarsus Pharmaceuticals, Viatris, Yuyu Pharma, Zeiss; Ownership Interests in Privately Held Companies: Avellino Group, Eyenovia, Horizon Surgical Systems, iView, Kala Bio, Okogen, OSRX, Puget Sound Therapeutics, Signal12, Sophia Bio, Sydnexis

Amy Nau, OD, FAAO, Dipl, CCLRT

Adjunct Associate Professor
New England College of Optometry
Co-Owner, Forefront Eye Care
Co-Founder/CEO, Eyewell
Boston, MA

Disclosures: Advisor, Consultant, Speaker, Honoraria Recipient: InMode; Speakers Bureau: Tarsus, Vital Tears; Equity Owner: Eyewell, Forefront Eye Care; Other: Educational Sponsorship: BioTissue, Dompé, Glaukos, InMode, LacriFill, Lumenis, Ocubio, RxSight

Faculty, Staff, and Planners’ Disclosures

In accordance with ACCME Guidelines, PER^® has identified and resolved all conflicts of interest for faculty, staff, and planners prior to the start of this activity by using a multistep process.

The staff of Physicians’ Education Resource^®, LLC, have no relevant financial relationships with ineligible companies.

This podcast, including the narration, was developed by PER^® editorial staff based on a live activity developed with this faculty. The narration was voiced by a PER staff member or by an AI tool.

To learn more about this topic, including clinical trial data of therapies used for neurotrophic keratitis, go to https://www.gotoper.com/courses/searching-for-silence-corneal-sensitivity-testing-in-nk-9b9i.

Release Date

June 15, 2026

Expiration Date

June 15, 2027

Off-Label Disclosure and Disclaimer

This activity may or may not discuss investigational, unapproved, or off-label use of drugs. Learners are advised to consult prescribing information for any products discussed. The information provided in this accredited activity is for continuing education purposes only and is not meant to substitute for the independent clinical judgment of a health care professional relative to diagnostic, treatment, or management options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER^® or any company that provided commercial support for this activity.